Neil Gregory Almstead - Jan 5, 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role: CHIEF TECHNICAL OPS OFFICER
Signature: /s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol: PTCT
Transactions as of: Jan 5, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/9/2023, 03:58 PM
Previous filing: Feb 3, 2022
Next filing: Jan 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTCT	Common Stock	Award	$0	+17K	+34.59%	$0.00	66.2K	Jan 5, 2023	Direct	F1, F2
transaction	PTCT	Common Stock	Award	$0	+710	+26.12%	$0.00	3.43K	Jan 5, 2023	By Spouse	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTCT	Stock Option (Right to Buy)	Award	$0	+36.3K		$0.00	36.3K	Jan 5, 2023	Common Stock	36.3K	$39.42	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024.
F2	Includes 298 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2022.
F3	This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.